White House Outlines New Drug Manufacturing Goals to Improve Supply Chain

The White House has laid out “bold goals” to use biomanufacturing breakthroughs to produce at least 25 percent of all active pharmaceutical ingredients (API) for small-molecule drugs in the U.S. within five years.
Source: Drug Industry Daily